JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kudoh, A.
Right arrow Articles by Matsuki, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kudoh, A.
Right arrow Articles by Matsuki, A.
Anesth Analg 2000;91:440-445
© 2000 International Anesthesia Research Society


GENERAL ARTICLES

Sevoflurane Stimulates Inositol 1,4,5-Trisphosphate in Skeletal Muscle

Akira Kudoh, MD, and Akitomo Matsuki, MD

Department of Anesthesiology, University of Hirosaki School of Medicine, Hirosaki, Japan

Address correspondence and reprint requests to Akira Kudoh, MD, Department of Anesthesiology, University of Hirosaki School of Medicine, 5 Zaifucho, Hirosaki 036, Aomori, Japan.

Inositol 1,4,5-triphosphate (IP3) plays an important role in excitation-contraction coupling and malignant hyperthermia in skeletal muscle. We investigated whether sevoflurane affects IP3 formation in L6 skeletal muscle cells and studied the mechanisms that modulate IP3. Sevoflurane stimulated IP3 production from a basal level of 78.4 ± 6.1 to 730.0 ± 53.1 pmol · mg · protein-1 in 2 mM of sevoflurane in a dose-dependent manner. A dose of 10 µM of U73122 (a phospholipase C antagonist) significantly decreased 0.8 mM of sevoflurane-stimulated IP3 production from 387.8 ± 24.7 to 247.8 ± 19.8 pmol · mg · protein-1. A dose of 100 µM of (p-amylcinnamoyl) anthranilic acid (a PLA2 antagonist) also significantly decreased sevoflurane-stimulated IP3 production to 282.0 ± 24.0 pmol · mg · protein-1. Exposure to 1 µM of genistein and tyrphostin A23 (tyrosine kinase inhibitors) significantly decreased sevoflurane-stimulated IP3 production to 241.0 ± 35.3 and 267.4 ± 32.9 pmol · mg · protein-1. Sevoflurane-stimulated IP3 production was significantly decreased by 10 µM of 8-(N,N-diethylamino) octyl-3,4-5-trimathoxybenzoate (an intracellular calcium antagonist) and 100 µM and 1 mM of guanosine 5'-O-(2-thiodiphosphate) (GDPßS), a guanosine 5'triphosphate-binding protein inhibitor. Elevation of IP3 production was significantly higher in halothane than in sevoflurane and isoflurane at the same concentration of 0.8 mM. We conclude that sevoflurane-stimulated IP3 production involves phospholipase C, phospholipase A2, tyrosine kinase, and guanosine 5'triphosphate-binding protein and the stimulation is associated with concentration of intracellular ionized calcium.

Implications: Inhaled anesthetics increase intracellular ionized calcium in the skeletal muscle cell and the ionized calcium increase is partly released from the intracellular store by inositol 1,4,5-triphosphate (IP3) formation. IP3 plays an important role in excitation-contraction coupling and malignant hyperthermia. We studied whether sevoflurane affects IP3 formation and the mechanisms that modulate IP3.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
B. Vivien, J.-S. David, J.-L. Hanouz, J. Amour, Y. Lecarpentier, P. Coriat, and B. Riou
The Paradoxical Positive Inotropic Effect of Sevoflurane in Healthy and Cardiomyopathic Hamsters
Anesth. Analg., July 1, 2002; 95(1): 31 - 38.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. Kudoh, H. Katagai, and T. Takazawa
Sevoflurane Increases Glucose Transport in Skeletal Muscle Cells
Anesth. Analg., July 1, 2002; 95(1): 123 - 128.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. Pouzet, J.-B. Lecharny, M. Dehoux, S. Paquin, M. Kitakaze, J. Mantz, and P. Menasche
Is there a place for preconditioning during cardiac operations in humans?
Ann. Thorac. Surg., March 1, 2002; 73(3): 843 - 848.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2000 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2000 by the International Anesthesia Research Society.